Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival …

KN Nguyen, I Aursnes, J Kjekshus - The American journal of cardiology, 1997 - Elsevier
The use of angiotensin-converting enzyme (ACE) inhibitors early after an acute myocardial
infarction to reduce mortality has been studied in several trials with inconsistent results …

Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease

JG Peterson, EJ Topol, SK Sapp, JB Young… - The American journal of …, 2000 - Elsevier
BACKGROUND: Several studies have suggested that there may be an interaction between
angiotensin-converting enzyme (ACE) inhibitors and aspirin in patients with congestive …

Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease

J Leor, H Reicher-Reiss, U Goldbourt, V Boyko… - Journal of the American …, 1999 - jacc.org
OBJECTIVES The purpose of this study was to investigate the significance of the possible
negative interaction between aspirin and angiotensin-converting enzyme (ACE) inhibitors …

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic …

R Latini, G Tognoni, AP Maggioni, MG Franzosi… - Journal of the American …, 2000 - jacc.org
OBJECTIVES We sought to determine whether the clinical effects of early angiotensin-
converting enzyme (ACE) inhibitor (ACEi) treatment for acute myocardial infarction (MI) are …

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival …

K Swedberg, P Held, J Kjekshus… - … England Journal of …, 1992 - Mass Medical Soc
Background. Long-term administration of angiotensin-converting—enzyme (ACE) inhibitors
has been shown to improve survival in patients with symptomatic left ventricular failure and …

Different angiotensin‐converting enzyme inhibitors have similar clinical efficacy after myocardial infarction

ML Hansen, GH Gislason, L Køber… - British journal of …, 2008 - Wiley Online Library
What is already known about this subject• Treatment with an angiotensin‐converting
enzyme (ACE) inhibitor benefits many patients with cardiovascular disease.• ACE inhibitors …

Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review

KK Tea, S Yusuf, M Pfeffer, L Kober, A Hall, J Pogue… - The Lancet, 2002 - thelancet.com
Background Results from a retrospective analysis of the Studies of Left Ventricular
Dysfunction (SOLVD) study suggest that angiotensin-converting-enzyme (ACE) inhibitors …

Effects of aspirin on angiotensin-converting enzyme inhibition and left ventricular dilation one year after acute myocardial infarction

M Oosterga, RL Anthonio, PJ de Kam MSc… - The American journal of …, 1998 - Elsevier
There are conflicting reports on the interaction of aspirin with angiotensin-converting
enzyme inhibitors in heart failure and systemic hypertension. A post hoc analysis of the …

Effects of early and late administration of angiotensin-converting enzyme inhibitors on mortality after myocardial infarction

EJ Rodrigues, MJ Eisenberg, L Pilote - The American journal of medicine, 2003 - Elsevier
BACKGROUND: Clinical trials demonstrating that angiotensin-converting enzyme (ACE)
inhibitors reduce mortality when prescribed following myocardial infarction have focused on …

The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial …

J McMurray, S Solomon, K Pieper, S Reed… - Journal of the American …, 2006 - jacc.org
Objectives: We attempted to compare the effect of an angiotensin-converting enzyme (ACE)
inhibitor and angiotensin receptor blocker (ARB) on atherosclerotic events. Background …